Other studies have found the same trends when evaluating ovarian, colorectal or breast cancer patient cohorts as we found in SCLC.43, 44, 45 At first sight, our results that high PD-L1 expression correlates with better oncological outcome might seem counterintuitive. The gene discussed is CD274; the disease is breast cancer.